DL
Dimerix Limited Stock: price and insider trades · Australia
Dimerix Limited: what insiders have been doing
Dimerix Limited has a thin disclosure history in our data (latest filing: 5 November 2026). New filings will appear here as soon as they are published. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2026FY ended June 2026 · cache
A$0.21
Analyst consensus
1 analystsA$1.90Target A$1.90(+802%)A$1.90
Income statement
RevenueA$4.4M
Gross profitA$4.4M100% margin
EBITDA-A$37M-851% margin
Net income-A$29.8M-685.3% margin
Valuation
Beta0.36
Balance sheet & cash
Market capA$126.1M
Total debtA$232.1k
Free Cash Flow-A$51.8M
Profitability & ownership
ROA-29.4%
% insiders22.2%
% institutions2.8%
Last declaration on 5 November 2026
Declarations1 total
- ShareASXISIN AU000000DXB7ASX:2924-03158555-3A705898
1 of 1 declaration
About Dimerix Limited
Dimerix Limited is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the Australian Securities Exchange under the ticker DMR.